Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S30-S32, 30 November 2006

Hypoglycaemic treatment in type 2 diabetic patients after myocardial infarction

Department of Internal Diseases, Diabetology and Nephrology, Silesian Medical Academy, Zabrze, Poland

published online 10 August 2006.

Abstract 

Type 2 diabetic (T2D) patients are particularly prone to macrovascular complications. Coronary heart disease is two to four times more frequent in T2D patients compared with non-diabetic individuals. Patients with diabetes mellitus who underwent acute MI have unfavourable prognosis. Diabetes and Insulin–Glucose Infusion in Acute MI study (DIGAMI) has shown that metabolic control by means of insulin–glucose i.v. infusion in the acute phase of MI followed by long-term intensive insulin therapy improves prognosis in the T2D patients. The DIGAMI-2 study did not confirm conclusions of DIGAMI 1 study. The authors of this article comment on the results of DIGAMI 2 and attempt to answer how T2D patients should be treated after MI.

Keywords: Type 2 diabetes, DIGAMI study, MI, Hypoglycaemic therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(06)00258-0

doi:10.1016/j.diabres.2006.06.010

Diabetes Research and Clinical Practice
Volume 74, Issue 2, Supplement , Pages S30-S32, 30 November 2006

Article Tools